DEFINITIVE PROXY STATEMENT

Company

BIOCRYST PHARMACEUTICALS INC

Filed

April 10, 2015

Period of Report

May 20, 2015

Accession Number

0001171843-15-001911

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →